Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|May 31, 2020
Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder CancerKati Erdmann, Karsten Salomo, Anna Klimova, et al.
Genes, Chromosomes & Cancer|November 6, 2012
PARK2 and PACRG are commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeMarieta I Toma, Daniela Wuttig, Sandy Kaiser, et al.
International Journal of Cancer|March 18, 2004
D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancerBernd Weigle, Andrea Kiessling, Reinhard Ebner, et al.
The Prostate|March 12, 2005
D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene familyAndrea Kiessling, Bernd Weigle, Susanne Fuessel, et al.
The Prostate|February 17, 2006
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trialSusanne Fuessel, Axel Meye, Marc Schmitz, et al.
Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.
BMC Cancer|November 25, 2017
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatmentDoreen Huebner, Christiane Rieger, Ralf Bergmann, et al.
Plos One|August 14, 2020
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancerHolger H H Erb, Julia Bodenbender, Florian Handle, et al.
Journal of Cellular Biochemistry|February 24, 2011
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonatesSylvia Thiele, Martina Rauner, Claudia Goettsch, et al.
International Journal of Cancer|September 12, 2019
Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostateAngelika Borkowetz, Michael Froehner, Martina Rauner, et al.
Pageof 9